Amplified Sciences, Inc.

Amplified Sciences, Inc. is a promising lifescience in-vitro diagnostic startup with the slogan "Ultra-sensitive sensing tech revolutionizing #pancreaticcancer & more diseases." Founded in 2016 in the United States, the company aims to revolutionize disease detection and preemptive healthcare. Leveraging IP licensed from Purdue University, it has developed a platform that can scale to point of care. Their flagship assay, an ultra-sensitive molecular sensing technology, is disrupting the field of #pancreaticcancer by enabling early detection and intervention. They also target other debilitating diseases in the fields of oncology and chronic kidney disease. Amplified Sciences received a significant $400.00K grant investment from the National Cancer Institute on 12 July 2023, reflecting confidence in their innovative approach to diagnostics. With its focus on biotechnology and healthcare, the company is strategically positioned to make a substantial impact on the early detection and treatment of life-threatening diseases. This startup has the potential to not only achieve commercial success but also significantly improve patient outcomes and healthcare strategies.